These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38404124)

  • 41. A computationally efficient nonparametric sampling (NPS) method of time to event for individual-level models.
    Garibay D; Jalal H; Alarid-Escudero F
    medRxiv; 2024 Apr; ():. PubMed ID: 38633801
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Flexible parametric models for relative survival, with application in coronary heart disease.
    Nelson CP; Lambert PC; Squire IB; Jones DR
    Stat Med; 2007 Dec; 26(30):5486-98. PubMed ID: 17893893
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluating Left-Censored Data Through Substitution, Parametric, Semi-parametric, and Nonparametric Methods: A Simulation Study.
    Tekindal MA; Erdoğan BD; Yavuz Y
    Interdiscip Sci; 2017 Jun; 9(2):153-172. PubMed ID: 26590921
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Introducing a new estimator and test for the weighted all-cause hazard ratio.
    Ozga AK; Rauch G
    BMC Med Res Methodol; 2019 Jun; 19(1):118. PubMed ID: 31185922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparing Survival Extrapolation within All-Cause and Relative Survival Frameworks by Standard Parametric Models and Flexible Parametric Spline Models Using the Swedish Cancer Registry.
    Chen EY; Leontyeva Y; Lin CN; Wang JD; Clements MS; Dickman PW
    Med Decis Making; 2024 Apr; 44(3):269-282. PubMed ID: 38314657
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Individual level covariate adjusted conditional autoregressive (indiCAR) model for disease mapping.
    Huque MH; Anderson C; Walton R; Ryan L
    Int J Health Geogr; 2016 Jul; 15(1):25. PubMed ID: 27473270
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Revisiting methods for modeling longitudinal and survival data: Framingham Heart Study.
    Ngwa JS; Cabral HJ; Cheng DM; Gagnon DR; LaValley MP; Cupples LA
    BMC Med Res Methodol; 2021 Feb; 21(1):29. PubMed ID: 33568059
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of Parametric Survival Extrapolation Approaches Incorporating General Population Mortality for Adequate Health Technology Assessment of New Oncology Drugs.
    van Oostrum I; Ouwens M; Remiro-Azócar A; Baio G; Postma MJ; Buskens E; Heeg B
    Value Health; 2021 Sep; 24(9):1294-1301. PubMed ID: 34452709
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A parametric method for cumulative incidence modeling with a new four-parameter log-logistic distribution.
    Shayan Z; Ayatollahi SM; Zare N
    Theor Biol Med Model; 2011 Nov; 8():43. PubMed ID: 22074546
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Application of Cox and Parametric Survival Models to Assess Social Determinants of Health Affecting Three-Year Survival of Breast Cancer Patients.
    Mohseny M; Amanpour F; Mosavi-Jarrahi A; Jafari H; Moradi-Joo M; Davoudi Monfared E
    Asian Pac J Cancer Prev; 2016; 17(S3):311-6. PubMed ID: 27165244
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Parameter estimation and goodness-of-fit in log binomial regression.
    Blizzard L; Hosmer DW
    Biom J; 2006 Feb; 48(1):5-22. PubMed ID: 16544809
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of survival analysis approaches to modelling age at first sex among youth in Kisesa Tanzania.
    Materu J; Konje ET; Urassa M; Marston M; Boerma T; Todd J
    PLoS One; 2023; 18(9):e0289942. PubMed ID: 37676876
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Bayesian goodness of fit test and semiparametric generalization of logistic regression with measurement data.
    Schörgendorfer A; Branscum AJ; Hanson TE
    Biometrics; 2013 Jun; 69(2):508-19. PubMed ID: 23489010
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Direct likelihood inference and sensitivity analysis for competing risks regression with missing causes of failure.
    Moreno-Betancur M; Rey G; Latouche A
    Biometrics; 2015 Jun; 71(2):498-507. PubMed ID: 25761785
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Utilization of a Mixture Cure Rate Model based on the Generalized Modified Weibull Distribution for the Analysis of Leukemia Patients.
    Omer ME; Abu Bakar M; Adam M; Mustafa M
    Asian Pac J Cancer Prev; 2021 Apr; 22(4):1045-1053. PubMed ID: 33906295
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Parametric multistate survival models: Flexible modelling allowing transition-specific distributions with application to estimating clinically useful measures of effect differences.
    Crowther MJ; Lambert PC
    Stat Med; 2017 Dec; 36(29):4719-4742. PubMed ID: 28872690
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fitting parametric cure models in R using the packages cuRe and rstpm2.
    Jensen RK; Clements M; Gjærde LK; Jakobsen LH
    Comput Methods Programs Biomed; 2022 Nov; 226():107125. PubMed ID: 36126436
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Case Study Examining the Usefulness of Cure Modelling for the Prediction of Survival Based on Data Maturity.
    Grant TS; Burns D; Kiff C; Lee D
    Pharmacoeconomics; 2020 Apr; 38(4):385-395. PubMed ID: 31848900
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A parametric model fitting time to first event for overdispersed data: application to time to relapse in multiple sclerosis.
    Siri P; Henninger E; Sormani MP
    Lifetime Data Anal; 2012 Apr; 18(2):139-56. PubMed ID: 22083507
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Power and sample size for randomized phase III survival trials under the Weibull model.
    Wu J
    J Biopharm Stat; 2015; 25(1):16-28. PubMed ID: 24895942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.